Seattle WA 淋巴瘤临床试验
12项针对 淋巴瘤的研究正在 Seattle及周边约 30 英里内的站点招募参与者。打开研究详情可查看入选标准及联系研究团队的方式。
官方研究文本（英文）
正在为研究招募参与者？将此页面置顶展示 — $99 / 30天 →
A Study of the Efficacy and Safety of Lisocabtagene Maraleucel (Liso-cel) as First-Line Therapy in Adults With Transplant-Ineligible Primary Central Nervous System Lymphoma
招募中2 期
- Fred Hutchinson Cancer Center, Seattle
A Study of NX-5948 in Adults With CLL/SLL Previously Treated With a Bruton's Tyrosine Kinase Inhibitor and a B-cell Lymphoma-2 Inhibitor (DAYBreak CLL-201)
招募中2 期
- Fred Hutchinson Cancer Center, Seattle
Collection of Tissue Samples for Cancer Research
招募中观察性研究
- Fred Hutchinson, Seattle
Cognitive Aftereffects of Neurotoxicity in Children and Young Adults With Relapsed/Refractory Hematologic Malignancies Who Receive CAR T-cell Therapy
招募中观察性研究欢迎健康志愿者
- Seattle Children s Hospital, Seattle
A Study of Tulmimetostat DZR123 (CPI-0209) in Patients With Advanced Solid Tumors and Lymphomas
招募中1/2 期
- Swedish Cancer Institute, Seattle
- Fred Hutchinson Cancer Center, Seattle
A Phase 1 Study of UB-VV111 With and Without Rapamycin in Relapsed/Refractory CD19+ B-cell Malignancies
招募中1 期
- Fred Hutch Cancer Center, Seattle
DALY II USA/ MB-CART2019.1 for DLBCL
招募中2 期
- Fred Hutchinson Cancer Center, Seattle
A Study of DR-01 in Subjects With Large Granular Lymphocytic Leukemia or Cytotoxic Lymphomas
招募中1/2 期
- Dren Investigational Site, Seattle
Effects of Dexrazoxane Hydrochloride on Biomarkers Associated With Cardiomyopathy and Heart Failure After Cancer Treatment
招募中观察性研究
- Seattle Children's Hospital, Seattle
CA-4948-101: Open-Label, Dose Escalation and Expansion Trial of Emavusertib (CA-4948) in Relapsed or Refractory Primary Central Nervous System Lymphoma (R/R PCNSL)
招募中1/2 期
- University of Washington Medical Center, Seattle
A Platform Protocol to Investigate Post-Transplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis in Patients With Hematologic Malignancies Undergoing Mismatched Unrelated Donor Peripheral Blood Stem Cell Transplantation
招募中2 期
- Fred Hutchinson Cancer Center, Seattle
A Randomized Phase II Study Of Bruton Tyrosine Kinase Inhibitor With Or Without Venetoclax In Veterans With Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL)
招募中2 期
- VA Puget Sound Health Care System Seattle Division, Seattle, WA, Seattle
其他城市的 淋巴瘤试验
- Houston, TX34 项研究
- Boston, MA33 项研究
- New York City, NY33 项研究
- Washington, DC23 项研究
- Baldwin Park, CA21 项研究
- Chicago, IL20 项研究
- Durham, NC17 项研究
- St. Louis, MO15 项研究
- Philadelphia, PA15 项研究
- Cleveland, OH14 项研究
- Edison, NJ12 项研究
- Atlanta, GA12 项研究
Seattle的其他研究
- 非小细胞肺癌53 项研究
- 癌症（所有类型）49 项研究
- 前列腺癌42 项研究
- 急性髓系白血病40 项研究
- 乳腺癌39 项研究
- 转移性癌症39 项研究
- 结直肠癌34 项研究
- 肺癌33 项研究
- 卵巢癌30 项研究
- 多发性骨髓瘤22 项研究
- 骨髓增生异常综合征21 项研究
- 急性淋巴细胞白血病21 项研究
数据来自 ClinicalTrials.gov，检索日期：2026年10月5日。每项研究自行设定入选标准，由研究团队决定谁能参与。